Avian oocyte-specific very low density lipoprotein receptor specifically binds human rhinovirus of the minor receptor group on ligand blots and in solution. The solubilized receptor protects cells against infection in a dose-dependent manner.
S-labeled HRV2 was detected by autoradiography of the membrane as described previously for the human LDLR (9, 15) . For detection of OVR with specific antisera (21) , membrane incubation was performed in phosphate-buffered saline (PBS) with 2% Tween 20 as the blocking agent, and the ECL System (Amersham) was employed for chemiluminescence detection. HRV2 prominently labeled a protein with an apparent molecular mass of 95 kDa (Fig. 1A, lane 1) . Incubation of a similar blot with an antiserum recognizing the 95-kDa OVR and crossreacting with the 380-kDa oocyte-specific ␣ 2 MR/LRP (21) revealed that HRV2 recognized the smaller oocyte receptor (lane 2). In addition to the 95-kDa OVR, a second band, with a slightly lower molecular mass, was also seen. This is presumably a degradation product, since it also reacted with the antiserum against OVR (lane 2).
Members of the LDLR family are known to bind Ca 2ϩ ions (5, 7, 16) . Therefore, blots obtained from oocyte membrane extracts (lane 3) and from chicken liver membrane extracts (21) (lane 4) were incubated with 1 Ci of 45 Ca 2ϩ (Amersham) per ml in 50 mM NaCl-5 mM MgCl 2 -15 mM Tris-HCl, pH 7 (7). As expected, the 95-kDa OVR as well as the oocytespecific ␣ 2 MR/LRP appeared as a prominently labeled band in the oocyte extract (lane 3). Depending on the preparation, a barely visible band with very high molecular weight was detected. This protein was the predominant Ca 2ϩ -binding polypeptide in liver extracts (lane 4) and is the somatic homolog of the ␣ 2 MR/LRP (18) , which is sometimes present in small amounts in the follicle membrane extract. It might be this protein which appears to be also recognized by HRV2 (lane 1, solid arrowhead). Control experiments were then carried out to study the specificity of binding. As expected from our previous experiments (9, 15) , excess cold HRV2 competed for binding of 35 S-labeled HRV2. Binding was also prevented by incubation in the presence of EDTA and/or by the heating of HRV2 to 56ЊC (data not shown).
Additional evidence for the attachment of HRV2 to OVR was obtained by transfection experiments. COS-7 cells were transfected with pCDMCVR-1, a vector expressing OVR under the control of the cytomegalovirus promoter (3), cell membranes were prepared, and solubilized proteins were separated on a nonreducing SDS-4.5 to 18% polyacrylamide gel. Proteins were transferred onto a Hybond membrane, and virusbinding polypeptides were revealed by ligand blotting with 35 S-labeled HRV2 (Fig. 1B, lane 3) . Comparison with the blot prepared from proteins present in oocyte membrane extracts (lane 1) again demonstrates specific binding of HRV2 to OVR. The 95-kDa band is missing in mock-transfected cells (lane 2). Overexposure of the film revealed weak bands in lanes 2 and 3 migrating at the position corresponding to the endogenous simian ␣ 2 MR/LRP (data not shown). The cells had been grown in 10% fetal calf serum in order to suppress LDLR expression (8, 20) ; consequently, the corresponding band was not visible in this experiment.
OVR attaches to HRV2 in solution. Having established the binding of HRV2 to OVR on ligand blots, we next assessed the interaction of these compounds in solution. About 50 g of a membrane extract enriched for OVR by VLDL-Sepharose affinity chromatography (2) and anion exchange chromatography on a MonoQ column (Pharmacia) was precleared by ultracentrifugation and incubated for 45 min at 30ЊC in a solution of PBS, 30 mM MgCl 2 , and 1 mM CaCl 2 containing 20 g of HRV2 followed by centrifugation through a 300-l 15% sucrose cushion made in a Beckman SW50.1 tube at 120,000 ϫ g for 1 h. Pellets were resuspended in Laemmli sample buffer without 2-mercaptoethanol and incubated at 56ЊC for 20 min in order to dissociate any possible complexes of virus and proteins. The mixture was then subjected to electrophoresis on a 4 to 12% polyacrylamide gradient gel and immunoblotting with anti-OVR antiserum (21) cross-reacting with the 380-kDa ␣ 2 MR/LRP (Fig. 1C , lane 2). As controls, extracts were centrifuged under the same conditions and subjected to the same blotting procedure with HRV2 heated to 56ЊC (lane 3) or with the major group rhinovirus HRV14 (lane 4) or were directly applied onto the gel (lane 1). From this set of experiments it becomes clear that solubilized OVR attached to HRV2 and was thus pelleted through the sucrose cushion, whereas the oocyte-specific ␣ 2 MR/LRP remained in the supernatant. HRV14 and heat-inactivated HRV2 failed to bind OVR. Determination of binding stoichiometry. Rhinoviruses are composed of 60 subunits, each containing one copy of the viral proteins VP1 through VP4. With the major group HRVs, amino acid residues at the bottom of the canyon, a crevice encircling the fivefold axis of symmetry of the icosahedral viral capsid, interact with intercellular adhesion molecule 1 (ICAM-1) (4, 19) . Soluble forms of ICAM-1 bind HRVs in a stoichiometric manner, i.e., 60 copies of the receptor protein attach to one virus particle and inactivate the virus by a mechanism that is as yet unknown. Attachment of the receptors leads to a shift in the sedimentation constant from 150 S for the native virus to about 135 S. Ultimately, the RNA is released and the resulting particles sediment at 80 S (6, 10). Therefore, it was investigated whether a similar situation exists in the case of minor group rhinoviruses. About 25 g of HRV2 was incubated with a molar excess of between 300 and 1,000 of purified OVR at 15) . The high sensitivity of the silver stain also revealed some contaminating proteins which escaped detection when Coomassie blue stain was used. When OVR was analyzed on an identical gradient in the absence of virus, all of the material remained on the top of the gradient, excluding the possibility that some aggregated receptor migrated to the same position as the virus (not shown). Fractions containing the complexes were pooled, and the complexes were pelleted and analyzed by SDS-polyacrylamide gel electrophoresis (Fig. 2B) . The absolute quantities of virus and receptor in the complex were determined by comparing densitometry results for the Coomassie blue-stained bands of VP1 and OVR with known amounts of HRV2 and OVR run on the same gels. Table 1 shows data compiled from two independent experiments with molar excesses of OVR over HRV2 of 500-and 1,000-fold; the molar ratio of OVR to HRV2 in the complex was found to be 26 to 36. OVR neutralizes viral infectivity. Since HRV2 forms stable complexes with OVR in solution, we investigated whether soluble OVR was able to inhibit viral infection. HeLa cells grown to confluency in 96-well microtiter plates were incubated overnight in infection medium (17) with purified OVR at various concentrations together with HRV2 at a multiplicity of infection of 25 (Fig. 3) . Control values were determined by incubation of virus with buffer without OVR. After 24 h at 34ЊC, cell layers were stained with crystal violet and the cytopathic effect was determined by measurement of A 450 with a microplate reader. The presence of more than 0.5 g of OVR per ml during viral challenge significantly increased the viability of the HeLa cells. These experiments clearly established that OVR protects the cells against infection in a dose-dependent manner.
Conclusions. The experiments clearly established that a human rhinovirus of the minor receptor group type (HRV2) is bound by the avian homolog of mammalian VLDL receptor, the 95-kDa OVR. Although the chicken receptors efficiently bind this minor receptor group HRV, avian cells are nonpermissive for infection. This is most probably due to a block in replication similar to that previously observed with mouse cells (24) .
Virus-receptor complexes sedimented slightly more slowly upon sucrose gradient centrifugation than did native virus. However, since no viral material sedimenting at 80 S was detected even after incubation for 5 h at 34ЊC (not shown) it appears highly improbable that OVR is able to uncoat HRV2. Attempts to determine the stoichiometry of binding between OVR and HRV2 yielded values clearly below 1:60. To decide whether this is due to steric hindrance or attachment to sites other than those used by ICAM-1 in the case of major group viruses has to await structure determination of the complexes by cryoelectron microscopy.
Despite the clear inhibition of viral infection by the presence of the receptor in the infection medium, we cannot decide so far whether this should be attributed to mere competition or to an inactivation process similar to that described for ICAM-1 and major group rhinoviruses (6, 10, 14) or for the poliovirus and poliovirus receptor system (11) . The protection of HeLa or WI-38 cells against infection by various major group HRVs required from 0.1 to more than 32 g of soluble ICAM-1 (1, 13) per ml; solubilized OVR at concentrations of about 1 g/ml was effective against HRV2 at a multiplicity of infection of about 25 (Fig. 3) .
The great abundance of OVR in chicken follicles and the ease of its purification will enable us to further study virusreceptor interactions with highly purified protein preparations. This work was supported by grants from the Austrian Science Foundation (P-10384-MOB to D.B., P-9040-MOB to W.J.S., and P-9508-MOB to J.N.) and Boehringer Ingelheim.
This work would not have been possible without the participation of Z. Rattler. FIG. 3 . Soluble OVR protects cells against infection. HeLa cells were grown to confluency in 96-well microtiter plates and incubated overnight with purified OVR at the concentrations indicated together with HRV2 at a multiplicity of infection of 25. Cells were stained with crystal violet, and the density of the cell layers was measured with a microplate reader. Data for 0.5 and 1 g/ml are the means of two independent experiments carried out in duplicate and those for 0, 2, and 4 g/ml are the means of four independent experiments carried out in duplicate. Error bars represent standard deviations. 
